Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Expensive Star
948.65 17.95 (1.93%)
NSE Sep 30, 2022 15:31 PM
Volume: 4.2M

Change is hard, and some Indian pharma companies are embracing it better than others
By Tejas MD


For Indian pharma companies, pandemic treatments became a significant moneymaker in FY22. Post-Covid, drug markers are shifting their attention back to their core product portfolio. 

This comes at a time when the US formulation business, which used to be a significant revenue contributor for Indian pharma, is facing intense competition in the generics space. Drug makers that quickly adapt …

Premium This is a premium article. Click here to read.

Number of FII/FPI investors increased from 938 to 955 in Jun 2022 qtr.
More from Sun Pharmaceutical Industries Ltd.
More from Tejas MD